$PBIO their technology has been developed for use in the
$PBIO their technology has been developed for use in the CBD manufacturing industry. The company's flagship product the BaroShear K45 is a unique and powerful next generation Nano emulsification system that uses the company's patented Ultra Sheer Technology Platform to process CBD oil into a water soluble end product without the use of harmful or expensive chemicals.
The company’s patented Ultra Sheer Technology Platform employs a nanotechnology technique that uses ultra-high pressure to sheer oil droplets to such a small size that they effectively dissolve in water tremendously increasing the absorption properties of the CBD within the body. Current methods of processing CBD oil create an end product that is not easily absorbed by the body and less than 10% of the CBD oil processed using today's inferior technologies is absorbed by the body when consumed.
The BaroShear K45 uses its proprietary, breakthrough technology to process CBD oil into an end product that is far more potent as up to 90% of the CBD can now be absorbed by the body when consumed which is now leading to the BaroShear 45 quickly becoming the industry standard for the processing of CBD oil. This incredible increase in the body's absorption level of the CBD is due to the improved physics that are created by processing CBD oil using Pressure BioSciences' BaroShear K45's superior nanotechnology based processing technology.
The resulting CBD product is as much as 9 times more potent and can be easily infused into CBD infused beverages and edibles while substantially decreasing the quantity of CBD necessary to create the same desired effect resulting in greatly improved efficiencies and increased profitability for CBD manufacturers. The significant decrease in the quantity of CBD being used to manufacture the exact same potency CBD infused products is leading to substantially increased margins throughout the industry.
Pressure BioSciences is creating a paradigm shift in the processing of CBD oil that is leading to the company experiencing exponential sales growth for its BaroShear K45 and an increased potential for enormous profits. The popularity of the BaroShear K45 is happening at a very opportune time in the CBD industry's history. With the passage of the 2018 Farm Bill, entrepreneurs are rushing to grow hemp and extract CBD oil that is water soluble to be used as an ingredient that is infused into beverages and edibles. Projected revenue for CBD infused beverages alone is expected to be $220 million by 2022
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...
Continue Reading
Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....
Continue Reading
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue Reading
Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...
Continue Reading
Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...
Continue Reading
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding xAI’s Vision for the Future of AI xAI is making headlines with its bold ambition to raise $15 billion, potentially valuing the company at a staggering $230 billion. This move marks a significant shift in how investments in artificial intelligence are considered. Traditionally, startup evaluations focused on immediate financial returns. However, xAI is...
Continue Reading
Wipro Forms Strategic Alliance with RELEX Solutions Wipro Limited (NYSE: WIT), a prominent player in technology services and consulting, has announced a significant strategic partnership with RELEX Solutions. This collaboration aims to leverage advanced technology in supply chain and retail planning, marking an important step in enhancing operational efficiency for their...
Continue Reading
Aker ASA Unveils Comprehensive Annual Report for 2024 Aker ASA, a prominent player in the maritime and energy sectors, is excited to share its Annual Report for 2024, showcasing not just its financial performance but also its dedication to sustainability. This document provides a robust overview of the company’s achievements and highlights significant environmental,...
Continue Reading
Transformative Power of AI in Infrastructure Management Artificial Intelligence (AI) is reshaping the way businesses operate, particularly in the realm of infrastructure management. StackGen, a trailblazer in autonomous infrastructure technology, has unveiled its groundbreaking Autonomous Infrastructure Platform. This innovative platform leverages AI agents designed to...
Continue Reading
Ensurge Micropower Successfully Completes Private Placement Ensurge Micropower ASA has announced the successful placement of its private placement, which has raised an impressive gross amount of NOK 100 million. This substantial financing comes from the allocation of 83,678,032 shares in Tranche 1, along with a conditional allocation of 27,433,079 shares in Tranche 2. All...
Continue Reading